1-5 of 5
Michael Schell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Age Is the Strongest Independent Prognostic Factor in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Moffitt Cancer Center Experience

Costanza Paoletti, Lodovico Balducci, MD, Ivette Boler, RN, Mihaela Popa-McKiver, MD, PhD, Martine Externann, MD, PhD, Jyotishankar Raychaudury, MD, Claudio Anasetti, MD, Hugo F. Fernandez, MD, Daniel Sullivan, MD, MS, William S. Dalton, MD, PhD, Teresa Field, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Lia Perez, MD, Janelle Perkins, William E. Janssen, PhD, John Harris, Michael Schell, Rachna Kapoor, MD, MPH, Melissa Alsina, J. Leonel Ochoa-Bayona
Journal: Blood
Blood (2008) 112 (11): 4435.
https://doi.org/10.1182/blood.V112.11.4435.4435
Published: 2008
Journal Articles

A Randomized, Controlled Trial of Graft-Versus-Host Disease (GVHD) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of GVHD, Relapse and Survival.

Janelle Perkins, Melissa Alsina, Claudio Anasetti, Ernesto Ayala, Hugo F. Fernandez, Mohamed Kharfan-Dabaja, Jose Leonel Ochoa-Bayona, Lia Perez, Jyotishankar Raychaudhuri, Dan Sullivan, Jongphil Kim, Michael Schell, Teresa Field
Journal: Blood
Blood (2008) 112 (11): 2235.
https://doi.org/10.1182/blood.V112.11.2235.2235
Published: 2008
Journal Articles

Expectation Bias-the Main Culprit for Large Number of Inconclusive Randomized Controlled Trials in Hematological Malignancies

Anja Magazin, Ambuj Kumar, MD, MPH, Heloisa Soares, Michael Schell, Iztok Hozo, Ph.D, Benjamin Djulbegovic, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 671.
https://doi.org/10.1182/blood.V112.11.671.671
Published: 2008
Journal Articles

Phase I/II Trial of High-Dose Melphalan (M) and Topotecan (T) Followed by Autologous Stem Cell Rescue in Patients ≤ 60 and > 60 Years of Age with Multiple Myeloma (MM).

Daniel Sullivan, MD, Melissa Alsina, MD, Claudio Anasetti, MD, Teresa Field, MD, PhD, Mohamed Kharfan-Dabaja, MD, Hugo Fernandez, MD, William Dalton, PhD, MD, Ernesto Ayala, MD, Jyoti Raychaudhuri, MD, Lia Perez, MD, Janelle Perkins, PharmD, Michael Schell, PhD, Christine McIsaac, RN, Beth Maddox, RN, Jana Gump, BS, Richard Lush, PhD, Tony Frudakis, PhD
Journal: Blood
Blood (2007) 110 (11): 943.
https://doi.org/10.1182/blood.V110.11.943.943
Published: 2007
Journal Articles

Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle.

Sophie Dessureault, MD, PhD, David Noyes, BSc, Jianguo Tao, MD, Lynn Moscinski, MD, Michael Schell, PhD, Scott J. Antonia, MD, PhD, Eduardo M. Sotomayor, MD
Journal: Blood
Blood (2007) 110 (11): 4483.
https://doi.org/10.1182/blood.V110.11.4483.4483
Published: 2007